(r) ampa

inactive enantiomer of AMPA

Selurampanel (BGG492) is an orally active and selective competitive AMPA glutamate receptor antagonist, a quinazoline-dione sulfonamide. selurampanel is used in the study of epilepsy, migraine and tinnitus.

Farampator (CX-691) (CX-691;Org24448) is a positive modulator of AMPA receptor.

rCRAMP (rat) acetate, a cathelin-related antimicrobial peptide, exhibits antibacterial activity in rat brain peptide/protein extracts.

Tulrampator (S-47445) is an orally bioavailable positive AMPAR modulator with antidepressant effects.

Irampanel hydrochloride (BIIR 561-CL) is an inhibitor of AMPA receptors and voltage-dependent sodium channels. It suppresses kainic acid-induced rat cortical neuronal currents.

Irampanel is a neuroprotectant and anticonvulsant.

Perampanel-[13C6] (Standard) is a reference standard of Perampanel-[13C6] intended for quantitative analysis, quality control, and related biochemical research applications.

KRP-199 sodium sodium is highly potent and selective for AMPA-R in vitro and exhibits good neuroprotection in vivo.

gamma-DGG acetate(6729-55-1 free base) (γ-D-Glutamylglycine) is a competitive blocker of AMPA receptor.

gamma-DGG is a competitive blocker of AMPA receptor.

MDK-5432, also known as AMPA stabilizer (R,R)-2a, is the most potent AMPA stabilizer.

NS1219 ((R)-SPD502), an isomer of NS1209, functions as a selective antagonist for AMPA receptors, exhibiting neuroprotective properties. This compound is utilized in research related to stroke, neuropathic pain, and epilepsy.

AMPA receptor modulator-6 is a unique dimeric positive allosteric modulator that effectively stabilizes the dimer interface of AMPA receptors by physically bridging two adjacent ligand-binding domains. This structural anchoring significantly slows receptor desensitization and deactivation, thereby enhancing glutamate-mediated synaptic transmission.

HBT1 is an AMPA receptor potentiator that induces production of brain-derived neurotrophic factor (BDNF) and exhibits little agonistic effect in primary neurons. HBT1 binds to ligand-binding domain of AMPA-R in glutamate dependent manner.